Glenmark Pharmaceuticals announced the FDA has approved Ryaltris, a fixed-dose (metered) combination nasal spray for the treatment of symptoms of Seasonal Allergic Rhinitis in adults…
RedHill Biopharma announced new data from a prespecified analysis of all patients with positive COVID-19 PCR test at screening enrolled in a phase 2/3 trial…
Novartis announced the U.S. FDA has approved Cosentyx (secukinumab) for the treatment of active enthesitis-related arthritis (ERA) in four years and older, and active juvenile psoriatic…
DBV Technologies announced plans to initiate a new phase 3 trial to investigate a modified Viaskin Peanut patch (mVP) for children ages 4 to 11…
ViiV Healthcare announced the U.S. FDA has approved Apretude (cabotegavir), the first and only long-acting injectable pre-exposure prophylactic (PrEP) option to reduce the risk of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
